期刊文献+

中国脊髓灰质炎Ⅱ型疫苗相关分离株病毒性状的观察 被引量:10

AN OBSERVATION ON MOLECULAR CHARACTERISTICS OF CHINA VACCINE-RELATED TYPE Ⅱ POLIOVIRUS
在线阅读 下载PDF
导出
摘要 对1994年中国分离的13株脊髓灰质炎Ⅱ型疫苗相关株进行了PCR-RFLP分析,发现7株为重组病毒,毒力较疫苗株有回复。在Ⅱ型脊髓灰质炎病毒基因序列上,对于神经毒力有重要影响的第481位核苷酸发生了突变(C→G),另一个被视为重要位点的第2908位核苷酸无一发生变化,反而在第2909位核苷发生了高频率的点突变,意味着2909位点在中国Ⅱ型疫苗相关株的自然变异中可能起着重要作用。根据转基因小鼠实验和温度敏感实验(Rct-marker),脊髓灰质炎病毒的神经毒力大小并不与温度敏感实验所显示的毒力特征呈正相关性。 Seven of the thirteen vaccine-related type Ⅱ polioviruses isolated in China were identified as recombinant strains by PCR-RFLP and sequencing analysis was made in 1994. With Transgenic mice test and Temperature-sensitive multiplication test (Rct-marker), most of them showed higher neurovirulence and higher ability of growth at 39.8℃ than Sabin2 vaccine strain but lower than that of MEF strain. However, the neurovirulence of the 7 isolates is not completely correlated with biological characteristics of Rct-marker. Partial genomic sequences of 5′non-coding region and VP1 region of these viruses were also examined. It was found that all recombinants have a transition from C to G at neucleotide position 481, some of them have T to A or T to C transition at position 2909, but non of them has mutation at position 2908 which is considered previously as one of the important points with type Ⅱ poliovirus neurovirulence.
出处 《病毒学报》 CAS CSCD 北大核心 1997年第4期332-338,共7页 Chinese Journal of Virology
基金 国家自然科学基金 卫生部科研基金
关键词 脊髓灰质炎 病毒 疫苗 神经毒力 Poliovirus, PCR-RFLP, Neurovirulence, Mutation
  • 相关文献

参考文献3

  • 1张礼璧,病毒学报,1994年,10卷,235页
  • 2郑渡平,病毒学报,1993年,9卷,337页
  • 3Ren R,J Virol,1991年,65卷,1377页

同被引文献22

  • 1郑渡平,张礼璧,侯晓辉,朱宏,Mac Otten,David R Kilpatnck,Mark Pallansch,Olen M Kew.1989-1994年中国脊髓灰质炎病毒的分子流行病学[J].病毒学报,1995,11(4):289-297. 被引量:3
  • 2严冬梅,王东艳,赵蓉,张勇,李杰,祝双利,安洪秋,张大勇,任刚,刘铭,苏飞,朱晖,叶绪芳,刘桂艳,唐牛良明,许文波.贵州省2004年分离到的脊髓灰质炎病毒分子生物学特征[J].中国计划免疫,2005,11(4):260-267. 被引量:7
  • 3李杰,张礼壁,米山彻夫,侯晓辉,郑红,方勇,原稔,荻原昭夫.中国脊髓灰质炎病毒疫苗株基因变异的分析[J].病毒学报,1996,12(4):291-298. 被引量:17
  • 4Balenant J, Guillot S, Cendrea A, et al. The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay[J] Virology, 1991,184:645 - 654.
  • 5Balanant J, GuiHot S, Candrea A, et al. The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay[J]. Virology, 1991,184 : 645 - 654.
  • 6Balanant J,Guillot S,Candrea A,et al.The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay.Virology,1991,184:645-654.
  • 7Balanant J.et al.The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay.Viology,1991,184:645-654.
  • 8Furione M,et al.Polioviruses with natural recombinant genomes isolated from vaccine associated paralytic poliomyelitis.Virology ,1993,196:199-208.
  • 9Li J,Zhang L B,Yoneyyama T,et al.Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients[J].Arch Virol,1996,141:1047-1054.
  • 10Ren R B,Moss E G,Racaniello V R,et al.Identification of two determinants that attenuate vaccine-related type Ⅱ poliovirus[J].J Virol,1991,65(3):1377-1382.

引证文献10

二级引证文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部